SOHLH2

Across TCGA pan-cancer cohorts, SOHLH2 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SOHLH2 data layer compared with 18 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher SOHLH2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SOHLH2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUSC, STAD, and LUAD are the cancer types where SOHLH2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	III,IV	0.001	0.684	<.001	44	view →
STAD	OS	Median	II,III,IV	0.167	0.666	<.001	15	view →
LUAD	OS	Median	III,IV	0.111	0.664	<.001	12	view →
LGG	DFS	Median	All	0.169	0.828	<.001	6	view →
UCEC	DFS	Median	All	0.928	0.604	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SOHLH2–LUSC (OS)

Open the LUSC breakdown →